CN107261209A - A kind of method of use phyllosilicate/chitosan self-assembled modified micro/nano-fibre film layer by layer - Google Patents

A kind of method of use phyllosilicate/chitosan self-assembled modified micro/nano-fibre film layer by layer Download PDF

Info

Publication number
CN107261209A
CN107261209A CN201710471996.8A CN201710471996A CN107261209A CN 107261209 A CN107261209 A CN 107261209A CN 201710471996 A CN201710471996 A CN 201710471996A CN 107261209 A CN107261209 A CN 107261209A
Authority
CN
China
Prior art keywords
membrane
micro
chitosan
substrate
layer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201710471996.8A
Other languages
Chinese (zh)
Other versions
CN107261209B (en
Inventor
邓红兵
陈佳佳
施晓文
杜予民
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wuhan University WHU
Original Assignee
Wuhan University WHU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wuhan University WHU filed Critical Wuhan University WHU
Priority to CN201710471996.8A priority Critical patent/CN107261209B/en
Publication of CN107261209A publication Critical patent/CN107261209A/en
Application granted granted Critical
Publication of CN107261209B publication Critical patent/CN107261209B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/02Inorganic materials
    • A61L27/025Other specific inorganic materials not covered by A61L27/04 - A61L27/12
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/18Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/20Polysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/22Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/227Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/22Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/24Collagen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54Biologically active materials, e.g. therapeutic substances
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/23Carbohydrates
    • A61L2300/236Glycosaminoglycans, e.g. heparin, hyaluronic acid, chondroitin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404Biocides, antimicrobial agents, antiseptic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/606Coatings
    • A61L2300/608Coatings having two or more layers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00Materials characterised by their function or physical properties
    • A61L2400/12Nanosized materials, e.g. nanofibres, nanoparticles, nanowires, nanotubes; Nanostructured surfaces
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00Materials characterised by their function or physical properties
    • A61L2400/18Modification of implant surfaces in order to improve biocompatibility, cell growth, fixation of biomolecules, e.g. plasma treatment
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2420/00Materials or methods for coatings medical devices
    • A61L2420/08Coatings comprising two or more layers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00Materials or treatment for tissue regeneration
    • A61L2430/02Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Artificial Filaments (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Materials For Medical Uses (AREA)
  • Compositions Of Macromolecular Compounds (AREA)

Abstract

本发明公开了一种用层状硅酸盐/壳聚糖层层自组装改性微/纳米纤维膜的方法,属于材料技术领域。本发明先制备带电荷的微/纳米纤维膜作为基板,根据基板的带电情况交替将带相反电荷的壳聚糖或层状硅酸盐组装于基板上,并将所得微/纳米纤维膜干燥,得到双层数为所需层数的复合微/纳米纤维膜。经过改性后的微/纳米纤维膜机械性能大大提高,亲水性增加,同时拥有抑菌性,且更适合成骨细胞在其表面的黏附、生长及分化。本发明首次选取层状硅酸盐单独作为组装材料,且具有条件温和,工艺简单,对底板材料的尺寸和形状没有任何限制,改性过程不引入其他杂质和不产生其他副产物等诸多优点。

The invention discloses a method for self-assembling and modifying micro/nano fiber membranes with layered silicate/chitosan layer by layer, and belongs to the field of material technology. In the present invention, a charged micro/nano fiber membrane is first prepared as a substrate, and oppositely charged chitosan or layered silicate is alternately assembled on the substrate according to the charging condition of the substrate, and the obtained micro/nano fiber membrane is dried, A composite micro/nanofibrous membrane with a desired number of layers is obtained. The modified micro/nanofibrous membrane has greatly improved mechanical properties, increased hydrophilicity, antibacterial properties, and is more suitable for the adhesion, growth and differentiation of osteoblasts on its surface. The present invention selects layered silicate alone as the assembly material for the first time, and has many advantages such as mild conditions, simple process, no restriction on the size and shape of the bottom plate material, and no other impurities and by-products are produced during the modification process.

Description

一种用层状硅酸盐/壳聚糖层层自组装改性微/纳米纤维膜的 方法A self-assembled layer-by-layer self-assembly of layered silicate/chitosan modified micro/nanofibrous membranes method

技术领域technical field

本发明属于材料技术领域,具体涉及一种用层状硅酸盐/壳聚糖层层自组装改性微/纳米纤维膜的方法。The invention belongs to the technical field of materials, and in particular relates to a method for self-assembling and modifying micro/nano fiber membranes with layered silicate/chitosan layer by layer.

背景技术Background technique

数十年来,骨组织工程的发展已使世界各地数百万患有骨缺损和骨创伤的的患者免受病魔的摧残。骨组织工程支架的研究也因此获得了大量的关注。理想的骨组织工程支架应满足两个基本要求。首先,支架应具有一定的机械强度,能够抵抗外力,并保持其物理结构稳定,从而保证稳定的细胞生长和组织发育。此外,适宜的表面性质和优异的生物相容性对于其促进成骨细胞的粘附,增殖和分化至关重要。For decades, the development of bone tissue engineering has saved millions of patients suffering from bone defects and bone trauma from the ravages of diseases all over the world. Therefore, the research on bone tissue engineering scaffolds has gained a lot of attention. An ideal scaffold for bone tissue engineering should meet two basic requirements. First, the scaffold should have a certain mechanical strength, be able to resist external forces, and keep its physical structure stable, thereby ensuring stable cell growth and tissue development. Furthermore, suitable surface properties and excellent biocompatibility are crucial for their promotion of osteoblast adhesion, proliferation, and differentiation.

微/纳米纤维膜作为一种具有特殊三维结构的微/纳米材料,在药物缓释、吸附过滤、等领域应用广泛,此外,由于其具有与细胞外基质相似的三维立体结构,能够模拟细胞外基质结构并提供细胞生长与粘附的支架,因此它也是一种重要的组织工程材料。大多微/纳米纤维的机械强度弱,表面光滑,不利于细胞的稳定生长,因此在应用于组织工程前,需要对其进行必要的改性。壳聚糖作为唯一带正电荷的天然碱性多糖,具有优异的生物相容性和抗菌活性,可在引入抗菌性能的同时保证材料的生物相容性不被破坏。层状硅酸盐可增强材料的机械强度,可调控微/纳米纤维膜表面的粗糙度,同时可促进壳聚糖的抑菌性能,这两种材料是理想的可用于微/纳米纤维膜改性的材料。As a micro/nano material with a special three-dimensional structure, the micro/nanofibrous membrane is widely used in drug sustained release, adsorption filtration, and other fields. In addition, because it has a three-dimensional structure similar to the extracellular matrix, it can simulate the extracellular matrix. Matrix structure and provide a scaffold for cell growth and adhesion, so it is also an important tissue engineering material. Most micro/nanofibers have weak mechanical strength and smooth surface, which is not conducive to the stable growth of cells, so they need to be modified before they are applied in tissue engineering. As the only positively charged natural alkaline polysaccharide, chitosan has excellent biocompatibility and antibacterial activity, which can ensure that the biocompatibility of the material is not destroyed while introducing antibacterial properties. Layered silicate can enhance the mechanical strength of the material, control the roughness of the micro/nanofibrous membrane surface, and at the same time promote the antibacterial properties of chitosan. These two materials are ideal for the improvement of micro/nanofiber membranes. sexual material.

中国专利“一种排列有序的改性微/纳米纤维膜及其制备和应用”(公开号CN106283399A)公开了一种排列有序的改性微/纳米纤维膜及其制备方法和应用前景。具体方法为:将胶原蛋白、丝素蛋白、聚己内酯以一定的比例共混,制成纺丝液,并进行静电纺丝,干燥,交联等步骤。通过共混和改变静电纺的收集器来制备有序微/纳米纤维,并达到改性目的。该专利中的改性虽然是在微/纳米纤维膜上进行,但其是通过共混和改变收集器来进行改性。在组织工程领域,由于涉及细胞的粘附、生长,材料的表面特性对于其性能有着重要的影响,共混的改性手段不仅会改变材料的表面,更会改变材料的主体,使材料主体的结构和性能带来未知的变化。而层层自组装的改性方法仅是在微/纳米纤维的表面进行修饰,不改变该微/纳米纤维的原有组分。The Chinese patent "A Modified Micro/Nanofiber Membrane with Orderly Arrangement and Its Preparation and Application" (publication number CN106283399A) discloses an orderedly arranged modified micro/nanofiber membrane and its preparation method and application prospect. The specific method is: blending collagen, silk fibroin and polycaprolactone in a certain proportion to prepare a spinning solution, and performing electrostatic spinning, drying, crosslinking and other steps. Ordered micro/nanofibers were prepared by blending and altering the collector of electrospinning, and achieved the purpose of modification. Although the modification in this patent is carried out on the micro/nano fiber membrane, it is modified by blending and changing the collector. In the field of tissue engineering, due to the adhesion and growth of cells, the surface characteristics of the material have an important impact on its performance. The modification method of blending will not only change the surface of the material, but also change the main body of the material, so that the Structure and performance bring about unknown changes. The modification method of layer-by-layer self-assembly is only to modify the surface of the micro/nano fiber without changing the original components of the micro/nano fiber.

层层自组装技术作为一种多功能有潜力的改性技术,具有操作简单,成本低,适用性强,对基底的大小及形状无要求等优点,可完成对基底微/纳米尺度上的可控改性,且改性材料的选择十分广泛。在层层自组装的过程中,具有相反电荷的聚电解质逐步、交替地吸附,该过程操作简便且不会产生其他副产物。此外,与在平板上的进行的层层自组装工艺相比,在微/ 纳米纤维膜上进行层层自组装改性的研究较为少见,它包含两个层面的改性:(1)在每根微/ 纳米纤维的表面进行改性;(2)在微/纳米纤维膜的宏观表面进行改性。在层层自组装过程之后,将得到微/纳米纤维膜多层级结构的多层次修饰。As a multifunctional and potential modification technology, layer-by-layer self-assembly technology has the advantages of simple operation, low cost, strong applicability, and no requirement on the size and shape of the substrate. Control modification, and the choice of modified materials is very wide. During the layer-by-layer self-assembly process, polyelectrolytes with opposite charges are adsorbed step by step and alternately, which is easy to operate and does not produce other by-products. In addition, compared with the layer-by-layer self-assembly process on the flat plate, the research on the layer-by-layer self-assembly modification on the micro/nanofiber membrane is relatively rare, which includes two levels of modification: (1) in each (2) modify the macroscopic surface of the micro/nanofiber membrane. After the layer-by-layer self-assembly process, a multi-level modification of the multi-level structure of the micro/nanofibrous membrane will be obtained.

基于上述考虑,选择微/纳米纤维作为底板,壳聚糖作为正电层组分和层状硅酸盐作为负电层组分,采用层层自组装的方法对微/纳米纤维膜进行改性,获得了拥有更强机械性能,抑菌性能和良好生物相容性的微/纳米纤维膜,在组织工程领域有非常广阔的应用前景。Based on the above considerations, micro/nanofibers were selected as the base plate, chitosan was used as the positive layer component and layered silicate was used as the negative layer component, and the micro/nanofiber membrane was modified by layer-by-layer self-assembly method. A micro/nanofibrous membrane with stronger mechanical properties, antibacterial properties and good biocompatibility has been obtained, which has a very broad application prospect in the field of tissue engineering.

发明内容Contents of the invention

本发明目的在于提供一种采用壳聚糖和层状硅酸盐对微/纳米纤维膜进行层层自组装改性的方法。该方法可以对微/纳米纤维膜进行改性,提高其物理和生物性能,制备出更适用于骨组织工程的微/纳米纤维膜。The purpose of the present invention is to provide a method for self-assembly modification of micro/nano fiber membrane layer by layer by using chitosan and layered silicate. The method can modify the micro/nano fiber membrane, improve its physical and biological properties, and prepare the micro/nano fiber membrane more suitable for bone tissue engineering.

本发明的目的通过下述技术方案实现:The object of the present invention is achieved through the following technical solutions:

一种用层状硅酸盐/壳聚糖层层自组装改性微/纳米纤维膜的方法,以带电荷的微/纳米纤维膜作为基板,当基板所带电荷为正时,依次在基板上组装层状硅酸盐和壳聚糖,直至达到所需双层数;当基板所带电荷为负时,依次在基板上组装壳聚糖和层状硅酸盐,直至达到所需双层数,将组装后的微/纳米纤维膜干燥,得到改性的微/纳米纤维膜。A method for modifying micro/nano fiber membranes by layer-by-layer self-assembly of layered silicate/chitosan, using charged micro/nano fiber membranes as the substrate, when the charge of the substrate is positive, sequentially on the substrate Assemble layered silicate and chitosan on top until the desired number of double layers is reached; when the charge on the substrate is negative, assemble chitosan and layered silicate on the substrate in turn until the desired number of double layers is reached number, the assembled micro/nanofibrous membrane was dried to obtain a modified micro/nanofibrous membrane.

优选地,所述基板的zeta电位绝对值不小于10mV。Preferably, the absolute value of the zeta potential of the substrate is not less than 10mV.

优选地,所述的所需双层数为1-50层。Preferably, the required number of double layers is 1-50 layers.

优选地,所述的带电荷的微/纳米纤维膜基板是由丝素蛋白、胶原蛋白、醋酸纤维素、壳聚糖及其衍生物、聚左旋乳酸、聚己内酯、聚乳酸-羟基乙酸共聚物中的一种或几种制备得到的。Preferably, the charged micro/nano fiber membrane substrate is made of silk fibroin, collagen, cellulose acetate, chitosan and its derivatives, poly-L-lactic acid, polycaprolactone, polylactic-glycolic acid One or more of the copolymers are prepared.

优选地,所述的微/纳米纤维膜基板由静电纺丝法、湿法纺丝法、干法纺丝法、离心纺丝法、相分离法或者复合纺丝法中的任一种制备得到。Preferably, the micro/nano fiber membrane substrate is prepared by any one of electrospinning method, wet spinning method, dry spinning method, centrifugal spinning method, phase separation method or composite spinning method .

优选地,所述的壳聚糖按照下述方法组装:配置壳聚糖醋酸溶液,将基板浸泡于带正电荷的壳聚糖醋酸溶液中,一定时间后,将膜取出,用清洗液清洗去除膜表面未组装成功的壳聚糖。Preferably, the chitosan is assembled according to the following method: configure the chitosan acetic acid solution, soak the substrate in the positively charged chitosan acetic acid solution, and after a certain period of time, take out the membrane and wash it with a cleaning solution to remove it. Chitosan was not successfully assembled on the membrane surface.

优选地,所述的层状硅酸盐按照下述方法组装:配置层状硅酸盐悬浮液,将基板浸泡于带负电荷的层状硅酸盐悬浮液中,一定时间后,将膜取出,用清洗液清洗去除膜表面未组装成功的层状硅酸盐。Preferably, the phyllosilicate is assembled according to the following method: configure the phyllosilicate suspension, soak the substrate in the negatively charged phyllosilicate suspension, and take out the film after a certain period of time , wash with cleaning solution to remove the unassembled phyllosilicate on the surface of the membrane.

优选地,所述的壳聚糖醋酸溶液浓度为0.1-10mg/mL。Preferably, the concentration of the chitosan acetic acid solution is 0.1-10 mg/mL.

优选地,所述的层状硅酸盐为蒙脱土或累托石。Preferably, the layered silicate is montmorillonite or rectorite.

优选地,所述的层状硅酸盐组装悬浮液浓度为0.1-10mg/mL。Preferably, the concentration of the phyllosilicate assembly suspension is 0.1-10 mg/mL.

优选地,所述的清洗液为去离子水或0.01-1mol/L的氯化钠溶液。Preferably, the cleaning solution is deionized water or 0.01-1 mol/L sodium chloride solution.

优选地,所述的浸泡组装时间为10-60分钟。Preferably, the soaking assembly time is 10-60 minutes.

优选地,所述的干燥方法为自然干燥、真空冷冻干燥或于真空干燥箱中烘干,所述干燥为完全干燥。Preferably, the drying method is natural drying, vacuum freeze drying or drying in a vacuum oven, and the drying is complete drying.

一种用层状硅酸盐/壳聚糖层层自组装改性的微/纳米纤维膜,通过上述的方法制备得到。A micro/nano fiber membrane self-assembled and modified layer by layer silicate/chitosan is prepared by the above method.

本发明以微/纳米纤维膜作为组装基底,通过静电力作用,交替在其多级结构表面组装壳聚糖和层状硅酸盐。壳聚糖的引入使纳米纤维膜具有了抑菌特性且保持了其良好的生物相容性。而层状硅酸盐单独作为带负电荷的组装材料被引入到复合纳米纤维膜中,大大增强了纤维膜的机械性能和表面特性。本发明具有诸多优点,包括条件温和,工艺简单,对底板材料的尺寸和形状没有任何限制,改性过程不引入其他杂质和不产生其他副产物等。The invention uses the micro/nano fiber film as an assembly base, and alternately assembles chitosan and layered silicate on the surface of the multi-level structure through the action of electrostatic force. The introduction of chitosan endowed the nanofibrous membrane with antibacterial properties and maintained its good biocompatibility. However, layered silicate alone was introduced into the composite nanofibrous membrane as a negatively charged assembly material, which greatly enhanced the mechanical properties and surface properties of the fibrous membrane. The invention has many advantages, including mild conditions, simple process, no restriction on the size and shape of the bottom plate material, and no other impurities or other by-products are introduced during the modification process.

附图说明Description of drawings

图1是实施例1制备的丝素蛋白纳米纤维膜和改性纳米纤维膜的形貌图。图中左侧是丝素蛋白纳米纤维膜表面扫描电镜图,右侧是双层数为15.5的层状硅酸盐/壳聚糖层层自组装改性纳米纤维膜表面扫描电镜图。Fig. 1 is the morphological diagram of the silk fibroin nanofiber membrane and the modified nanofiber membrane prepared in Example 1. The left side of the figure is the scanning electron microscope image of the surface of the silk fibroin nanofiber membrane, and the right side is the scanning electron microscope image of the layered silicate/chitosan layer-by-layer self-assembled modified nanofiber membrane with a double layer number of 15.5.

图2是实施例1制备的丝素蛋白纳米纤维膜和改性纳米纤维膜的纤维直径分布图。a是丝素蛋白纳米纤维膜的纤维直径分布图,b是双层数为15.5的层状硅酸盐/壳聚糖层层自组装改性纳米纤维膜的纤维直径分布图。Fig. 2 is a graph of fiber diameter distribution of the silk fibroin nanofiber membrane and the modified nanofiber membrane prepared in Example 1. a is the fiber diameter distribution diagram of the silk fibroin nanofiber membrane, and b is the fiber diameter distribution diagram of the layer-by-layer silicate/chitosan self-assembled modified nanofiber membrane with a bilayer number of 15.5.

图3是实施例1制备的丝素蛋白纳米纤维膜和改性纳米纤维膜的接触角随时间变化曲线。 a是丝素蛋白纳米纤维膜的接触角随时间变化曲线,b是双层数为15.5的层状硅酸盐/壳聚糖层层自组装改性纳米纤维膜的接触角随时间变化曲线。Fig. 3 is a time-dependent curve of the contact angle of the silk fibroin nanofiber membrane and the modified nanofiber membrane prepared in Example 1. a is the contact angle variation curve of silk fibroin nanofiber membrane with time, b is the contact angle variation curve of layer-by-layer silicate/chitosan self-assembled modified nanofiber membrane with a bilayer number of 15.5.

图4是实施例1制备的丝素蛋白纳米纤维膜和改性纳米纤维膜的拉伸强度和断裂伸长率对比图。图中,a表示丝素蛋白纳米纤维膜,b表示双层数为5的层状硅酸盐/壳聚糖层层自组装改性纳米纤维膜,c表示双层数为10的层状硅酸盐/壳聚糖层层自组装改性纳米纤维膜, d表示双层数为15的层状硅酸盐/壳聚糖层层自组装改性纳米纤维膜表面扫描电镜图,e表示双层数为15.5的层状硅酸盐/壳聚糖层层自组装改性纳米纤维膜。Fig. 4 is a comparison chart of tensile strength and elongation at break of the silk fibroin nanofiber membrane prepared in Example 1 and the modified nanofiber membrane. In the figure, a represents the silk fibroin nanofiber membrane, b represents the layer-by-layer silicate/chitosan layer-by-layer self-assembled modified nanofiber membrane with a double-layer number of 5, and c represents the layered silica with a double-layer number of 10. Salt/chitosan layer-by-layer self-assembled modified nanofibrous membrane, d represents the surface scanning electron microscope image of the layered silicate/chitosan layer-by-layer self-assembled modified nanofiber membrane with a double layer number of 15, e represents the bilayer Layer-by-layer self-assembly of layered silicate/chitosan modified nanofibrous membrane with 15.5 layers.

图5是成骨细胞在实施例1中制备的丝素蛋白纳米纤维膜和改性纳米纤维膜表面培养72 h后生长情况的扫描电镜图。a表示丝素蛋白纳米纤维膜,b表示双层数为15.5的层状硅酸盐 /壳聚糖层层自组装改性纳米纤维膜。Fig. 5 is a scanning electron microscope image of the growth of osteoblasts on the surface of the silk fibroin nanofibrous membrane prepared in Example 1 and the surface of the modified nanofibrous membrane cultured for 72 h. a represents the silk fibroin nanofiber membrane, and b represents the layer-by-layer silicate/chitosan self-assembled modified nanofiber membrane with a bilayer number of 15.5.

具体实施方式detailed description

下面通过具体实施例对本发明的技术方案做进一步说明,其目的在于帮助更好的理解本发明的内容,但这些具体实施方案不以任何方式限制本发明的保护范围。The technical solutions of the present invention are further described below through specific examples, the purpose of which is to help better understand the content of the present invention, but these specific embodiments do not limit the protection scope of the present invention in any way.

1,制备带电荷的微/纳米纤维膜1. Preparation of Charged Micro/Nanofibrous Membranes

以丝素蛋白为例:Take silk fibroin as an example:

将丝素蛋白溶解于六氟异丙醇溶剂中,磁力搅拌24h,得到7wt%的丝素蛋白纺丝液。然后通过静电纺丝技术制备丝素蛋白纳米纤维膜,静电纺丝相关参数为:电压为16kV,纺丝液推进速度为1mL/h,纺丝针与接收器之间距离为12cm,相对温度和相对湿度分别为25℃和40%。随后将所得的电纺丝素蛋白纳米纤维膜在55℃下真空干燥,使得残留溶剂充分挥发。The silk fibroin was dissolved in a hexafluoroisopropanol solvent, and magnetically stirred for 24 hours to obtain a 7wt% silk fibroin spinning solution. Then, the silk fibroin nanofiber membrane was prepared by electrospinning technology. The relevant parameters of electrospinning were: the voltage was 16kV, the spinning solution advancing speed was 1mL/h, the distance between the spinning needle and the receiver was 12cm, the relative temperature and The relative humidity was 25°C and 40%, respectively. Subsequently, the obtained electrospun fibroin nanofiber membrane was vacuum-dried at 55° C., so that the residual solvent was fully volatilized.

本领域技术人员根据实际情况还可以选用胶原蛋白、醋酸纤维素、壳聚糖及其衍生物、壳寡糖、聚乳酸、聚乳酸-羟基乙酸共聚物、聚己内酯、聚苯乙烯、聚甲基丙烯酸甲酯、聚乙烯醇、甲基丙烯酸酯化聚乙烯亚胺、聚丙烯腈、聚氨酯、聚异丁烯中的一种或几种作为微/纳米纤维膜的原材料,并根据选用的原材料选用适当的溶剂和制备方法进行制备。Those skilled in the art can also choose collagen, cellulose acetate, chitosan and its derivatives, chitosan oligosaccharide, polylactic acid, polylactic acid-glycolic acid copolymer, polycaprolactone, polystyrene, poly One or more of methyl methacrylate, polyvinyl alcohol, methacrylated polyethyleneimine, polyacrylonitrile, polyurethane, and polyisobutylene are used as raw materials for micro/nano fiber membranes, and are selected according to the selected raw materials Appropriate solvents and preparation methods are used for preparation.

可选用的溶剂包括六氟异丙醇、三氯甲烷、二氯甲烷、三氟乙酸、四氢呋喃、苯、甲苯、苯乙醚、氯苯、N,N二甲基甲酰胺、N,N-二甲基乙酰胺、甲酸乙酯、乙酸乙酯、醋酸、磷酸、甲醇、甲酸、戊醇、水中的一种或多种作为溶剂,配置浓度为3-30wt%的纺丝液。Available solvents include hexafluoroisopropanol, chloroform, dichloromethane, trifluoroacetic acid, tetrahydrofuran, benzene, toluene, phenetole, chlorobenzene, N,N dimethylformamide, N,N-dimethylformamide One or more of acetamide, ethyl formate, ethyl acetate, acetic acid, phosphoric acid, methanol, formic acid, amyl alcohol, and water are used as solvents, and the spinning solution with a concentration of 3-30wt% is prepared.

可选用的制备方法包括静电纺丝法、湿法纺丝法、干法纺丝法、离心纺丝法、相分离法以及复合纺丝法。The available preparation methods include electrostatic spinning method, wet spinning method, dry spinning method, centrifugal spinning method, phase separation method and composite spinning method.

需要指出的是,本领域技术人员结合本领域公知常识对于这些原料、溶剂、制备方法的选择,并不影响本发明对微/纳米纤维膜的改性方法和最终得到的产品,采用本发明所述的方法对这些原料、溶剂和制备方法得到的微/纳米纤维膜进行改性,均属于本发明的保护范围。It should be pointed out that the selection of these raw materials, solvents, and preparation methods by those skilled in the art in combination with common knowledge in the art does not affect the modification method of the micro/nano fiber membrane and the final product obtained by the present invention. The modification of the micro/nano fiber membranes obtained by these raw materials, solvents and preparation methods by the above methods all belong to the protection scope of the present invention.

此外,当选用的微/纳米纤维膜本身不带电荷或所带电荷较少(zeta电位绝对值小于 10mV),可通过溶胶-凝胶技术、液相沉积、气相沉积、湿化学法、等离子体处理、接枝共聚、原位聚合使其表面电荷增强。In addition, when the selected micro/nano fiber membrane itself has no charge or less charge (the absolute value of zeta potential is less than 10mV), it can be processed by sol-gel technology, liquid deposition, vapor deposition, wet chemical method, plasma Treatment, graft copolymerization, and in-situ polymerization can enhance the surface charge.

以聚己内酯为例:Take polycaprolactone as an example:

将聚己内酯溶解于六氟异丙醇中,磁力搅拌24h,得到10wt%的聚己内酯纺丝液。然后通过静电纺丝技术制备得到聚己内酯纳米纤维膜,静电纺丝相关参数为:电压为15kV,纺丝液推进速度为2mL/h,纺丝针与接收器之间距离为10cm,相对温度和相对湿度分别为25℃和40%。随后将所得的电纺聚已内酯纳米纤维膜在55℃下真空干燥,使得残留溶剂充分挥发。随后采用湿化学法,将聚己内酯于50%的乙醇溶液中浸泡2小时,再将其置于1.0mg/mL的聚乙烯胺的0.15mol/L的氯化钠溶液中,10分钟后取出,用去离子水冲洗三次,即得到带正电荷的聚己内酯纳米纤维膜。Polycaprolactone was dissolved in hexafluoroisopropanol, and magnetically stirred for 24 hours to obtain a 10 wt% polycaprolactone spinning solution. Then, the polycaprolactone nanofiber membrane was prepared by electrospinning technology, and the relevant parameters of electrospinning were: the voltage was 15kV, the spinning solution propulsion speed was 2mL/h, and the distance between the spinning needle and the receiver was 10cm. The temperature and relative humidity were 25°C and 40%, respectively. The resulting electrospun polycaprolactone nanofiber membrane was then vacuum-dried at 55 °C to allow the residual solvent to fully evaporate. Then using wet chemical method, soak polycaprolactone in 50% ethanol solution for 2 hours, then place it in 0.15mol/L sodium chloride solution of 1.0mg/mL polyvinylamine, after 10 minutes Take it out and rinse it three times with deionized water to obtain a positively charged polycaprolactone nanofiber membrane.

以醋酸纤维素为例:Take cellulose acetate as an example:

将丙酮和N,N-二甲基乙酰胺以2:1(w/w)的比例混合,并将醋酸纤维素溶于该混合溶液中,得到16wt%的醋酸纤维素纺丝液。然后通过静电纺丝技术制备得到醋酸纤维素纳米纤维膜,静电纺丝相关参数为:电压为16kV,纺丝液推进速度为1mL/h,纺丝针与接收器之间距离为15cm,相对温度和相对湿度分别为25℃和45%。随后将所得的电纺聚已内酯纳米纤维膜在55℃下真空干燥,使得残留溶剂充分挥发。随后将所得醋酸纤维素纳米纤维膜浸泡于0.05mol/L氢氧化钠溶液中7天,取出后用去离子水漂洗,得到带负电荷的纤维素纳米纤维膜。Acetone and N,N-dimethylacetamide were mixed at a ratio of 2:1 (w/w), and cellulose acetate was dissolved in the mixed solution to obtain a 16 wt% cellulose acetate spinning solution. Then, the cellulose acetate nanofiber membrane was prepared by electrospinning technology, and the parameters related to electrospinning were: the voltage was 16kV, the spinning solution propulsion speed was 1mL/h, the distance between the spinning needle and the receiver was 15cm, and the relative temperature and relative humidity were 25°C and 45%, respectively. The resulting electrospun polycaprolactone nanofiber membrane was then vacuum-dried at 55 °C to allow the residual solvent to fully evaporate. Then soak the obtained cellulose acetate nanofiber membrane in 0.05 mol/L sodium hydroxide solution for 7 days, take it out and rinse it with deionized water to obtain a negatively charged cellulose nanofiber membrane.

以丝素蛋白为例:Take silk fibroin as an example:

将磷酸与甲酸以不同的比例进行混合,将丝素蛋白溶解在该混合溶液中,对该混合溶液进行过滤和消泡处理,得到浓度为15%的丝素蛋白纺丝液;以甲酸为凝固液,采用湿法纺丝技术制备微/纳米纤维膜。湿法纺丝相关参数为:纺丝液推进速度为30mL/h,相对温度和相对湿度分别为25℃和40%。随后将所得的湿法纺丝素蛋白微/纳米纤维膜在甲醇中浸泡24h,使其完全固化和结晶,并除去残留甲酸。然后再将丝素蛋白微/纳米纤维浸入60℃蒸馏水中 15分钟,随后进行5倍牵伸。最后进行张力干燥,防止干燥过程中收缩。Mix phosphoric acid and formic acid in different proportions, dissolve silk fibroin in the mixed solution, filter and defoam the mixed solution to obtain a silk fibroin spinning solution with a concentration of 15%; use formic acid as the coagulation Liquid, using wet spinning technology to prepare micro/nanofibrous membranes. The parameters related to wet spinning are: the advancing speed of spinning solution is 30mL/h, and the relative temperature and relative humidity are 25°C and 40%, respectively. The resulting wet-spun fibroin micro/nanofiber membrane was then soaked in methanol for 24 h to completely solidify and crystallize and remove residual formic acid. Then the silk fibroin micro/nanofibers were immersed in 60°C distilled water for 15 minutes, followed by 5 times stretching. Finally, tension drying is carried out to prevent shrinkage during drying.

2,对得到的微/纳米纤维膜进行层层自组装改性2. Layer-by-layer self-assembly modification of the obtained micro/nanofibrous membrane

实施例1Example 1

(1)得到zeta电位小于-10mV的丝素蛋白微/纳米纤维膜;(1) obtain the silk fibroin micro/nanofibrous film that zeta potential is less than-10mV;

(2)将壳聚糖粉末加入到0.5wt%的醋酸溶液中,磁力搅拌3-5h至溶液澄清透明,使壳聚糖充分溶解,配制得到浓度为1mg/mL的壳聚糖溶液。将丝素蛋白微/纳米纤维膜浸泡于所得的壳聚糖溶液中,使膜与溶液充分接触,20分钟后将膜取出,采用去离子水清洗三次去除膜表面未组装成功的壳聚糖;(2) Add chitosan powder into 0.5wt% acetic acid solution, stir magnetically for 3-5 hours until the solution is clear and transparent, fully dissolve chitosan, and prepare a chitosan solution with a concentration of 1 mg/mL. Soak the silk fibroin micro/nanofiber membrane in the obtained chitosan solution, make the membrane fully contact with the solution, take out the membrane after 20 minutes, wash it with deionized water three times to remove the unassembled chitosan on the membrane surface;

(3)累托石加入到去离子水中,采用超声仪进行分散,制备得到浓度为1mg/mL的累托石悬浮液,将组装了壳聚糖的丝素蛋白纳米纤维膜浸入到所得的累托石悬浮液中,使膜与溶液充分接触,20分钟后将膜取出,采用去离子水清洗三次去除膜表面未组装成功的累托石,至此组装成功了一个双层;(3) The rectorite is added into deionized water, dispersed by an ultrasonic instrument, and the rectorite suspension with a concentration of 1mg/mL is prepared, and the silk fibroin nanofiber membrane assembled with chitosan is immersed in the obtained pump Put the membrane in the suspension of the stalactite, make the membrane fully contact with the solution, take out the membrane after 20 minutes, wash it with deionized water three times to remove the unassembled rectorite on the surface of the membrane, and a double layer has been successfully assembled so far;

(4)依次重复步骤(2)和步骤(3)若干次,将所得微/纳米纤维膜干燥,分别得到双层数为5、10、15、15.5的复合微/纳米纤维膜。(4) Repeat step (2) and step (3) several times in sequence, and dry the obtained micro/nanofiber membrane to obtain composite micro/nanofiber membranes with double layers of 5, 10, 15, and 15.5, respectively.

所得丝素蛋白纳米纤维膜和改性纳米纤维膜的形貌见图1,图1左侧是丝素蛋白纳米纤维膜表面扫描电镜图,图1右侧是双层数为15.5的累托石/壳聚糖层层自组装改性纳米纤维膜表面扫描电镜图。可以看出,改性过后的纳米纤维的微观形貌发生了明显的改变,表面变粗糙。而且,改性后纤维平均直径为594±112nm增加为886±143nm(图2)。同时,改性后的纳米纤维膜机械性能增强至5.64Mpa(图4),水接触角降低至60.3°(图3),且水接触角在与膜接触后6.4s内将为0,亲水性增加。与改性前丝素蛋白纳米纤维膜相比,改性后的纳米纤维膜生物相容性增加,更适宜成骨细胞的黏附、生长和迁移(图5)。The morphology of the resulting silk fibroin nanofiber membrane and the modified nanofiber membrane is shown in Figure 1, the left side of Figure 1 is a scanning electron microscope image of the surface of the silk fibroin nanofiber membrane, and the right side of Figure 1 is the rectorite with a double layer number of 15.5 /Chitosan layer-by-layer self-assembled modified nanofiber membrane surface scanning electron microscope image. It can be seen that the microscopic morphology of the modified nanofibers has changed significantly, and the surface has become rough. Moreover, the average diameter of the modified fibers increased from 594±112 nm to 886±143 nm (Fig. 2). At the same time, the mechanical properties of the modified nanofibrous membrane were enhanced to 5.64Mpa (Figure 4), and the water contact angle was reduced to 60.3° (Figure 3), and the water contact angle would be 0 within 6.4s after contacting the membrane, showing a hydrophilic sex increased. Compared with the modified silk fibroin nanofiber membrane, the modified nanofiber membrane has increased biocompatibility and is more suitable for the adhesion, growth and migration of osteoblasts (Fig. 5).

实施例2Example 2

(1)得到zeta电位大于+10mV的聚己内酯微/纳米纤维膜;(1) Obtain a polycaprolactone micro/nanofiber membrane with a zeta potential greater than +10mV;

(2)蒙脱土加入到去离子水中,采用超声仪进行分散,制备得到浓度为1mg/mL的蒙脱土悬浮液,将带正电荷的聚己内酯纳米纤维膜浸入到所得的蒙脱土悬浮液中,使膜与溶液充分接触,20分钟后将膜取出,采用去离子水清洗三次去除膜表面未组装成功的蒙脱土;(2) Montmorillonite is added to deionized water, dispersed by an ultrasonic instrument, and a suspension of montmorillonite with a concentration of 1 mg/mL is prepared, and the positively charged polycaprolactone nanofiber membrane is immersed in the obtained montmorillonite In the soil suspension, the membrane was fully contacted with the solution, and the membrane was taken out after 20 minutes, and washed three times with deionized water to remove the unassembled montmorillonite on the membrane surface;

(3)将壳聚糖粉末加入到0.5wt%的醋酸溶液中,磁力搅拌3-5h至溶液澄清透明,使壳聚糖充分溶解,配制得到浓度为1mg/mL的壳聚糖溶液。将组装了累托石的聚己内酯纳米纤维膜浸泡于所得的壳聚糖溶液中,使膜与溶液充分接触,20分钟后将膜取出,采用去离子水清洗三次去除膜表面未组装成功的壳聚糖,至此组装成功了一个双层;(3) Add chitosan powder into 0.5wt% acetic acid solution, stir magnetically for 3-5 hours until the solution is clear and transparent, fully dissolve chitosan, and prepare a chitosan solution with a concentration of 1 mg/mL. Soak the polycaprolactone nanofiber membrane assembled with rectorite in the obtained chitosan solution, make the membrane fully contact with the solution, take out the membrane after 20 minutes, and wash it three times with deionized water to remove the unassembled surface of the membrane. Chitosan, so far assembled a double layer;

(4)依次重复步骤(2)和步骤(3)若干次,将所得微/纳米纤维膜干燥,即可获得双层数为所需层数的复合纳米纤维膜。(4) Step (2) and step (3) are repeated several times in sequence, and the obtained micro/nanofiber membrane is dried to obtain a composite nanofiber membrane with the required number of layers.

实施例3Example 3

(1)得到zeta电位小于-10mV的醋酸纤维素微/纳米纤维膜;(1) Obtain a cellulose acetate micro/nano fiber membrane with zeta potential less than -10mV;

(2)将壳聚糖粉末加入到0.5wt%的醋酸溶液中,磁力搅拌3-5h至溶液澄清透明,使壳聚糖充分溶解,配制得到浓度为10mg/mL的壳聚糖溶液。将纤维素纳米纤维膜浸泡于所得的壳聚糖溶液中,使膜与溶液充分接触,20分钟后将膜取出,采用去离子水清洗三次去除膜表面未组装成功的壳聚糖;(2) Add chitosan powder into 0.5wt% acetic acid solution, stir magnetically for 3-5 hours until the solution is clear and transparent, fully dissolve chitosan, and prepare a chitosan solution with a concentration of 10 mg/mL. Soak the cellulose nanofiber membrane in the obtained chitosan solution, make the membrane fully contact with the solution, take out the membrane after 20 minutes, and wash it three times with deionized water to remove the unassembled chitosan on the membrane surface;

(3)累托石加入到去离子水中,采用超声仪进行分散,制备得到浓度为10mg/mL的累托石悬浮液,将组装了壳聚糖的纤维素纳米纤维膜浸入到所得的累托石悬浮液中,使膜与溶液充分接触,20分钟后将膜取出,采用去离子水清洗三次去除膜表面未组装成功的累托石,至此组装成功了一个双层;(3) The rectorite is added to deionized water, dispersed by an ultrasonic instrument, and a rectorite suspension with a concentration of 10 mg/mL is prepared, and the cellulose nanofiber membrane assembled with chitosan is immersed in the obtained rectorite In the rock suspension, make the film fully contact with the solution, take out the film after 20 minutes, wash it with deionized water three times to remove the unassembled rectorite on the film surface, and a double layer has been successfully assembled so far;

(4)依次重复步骤(2)和步骤(3)若干次,将所得微/纳米纤维膜干燥,即可获得双层数为所需层数的复合纳米纤维膜。(4) Step (2) and step (3) are repeated several times in sequence, and the obtained micro/nanofiber membrane is dried to obtain a composite nanofiber membrane with the required number of layers.

实施例4Example 4

(1)得到zeta电位小于-10mV的丝素蛋白微/纳米纤维膜;(1) obtain the silk fibroin micro/nanofibrous film that zeta potential is less than-10mV;

(2)将壳聚糖粉末加入到0.5wt%的醋酸溶液中,磁力搅拌3-5h至溶液澄清透明,使壳聚糖充分溶解,配制得到浓度为1mg/mL的壳聚糖溶液。将丝素蛋白微/纳米纤维膜浸泡于所得的壳聚糖溶液中,使膜与溶液充分接触,20分钟后将膜取出,采用去离子水清洗三次去除膜表面未组装成功的壳聚糖;(2) Add chitosan powder into 0.5wt% acetic acid solution, stir magnetically for 3-5 hours until the solution is clear and transparent, fully dissolve chitosan, and prepare a chitosan solution with a concentration of 1 mg/mL. Soak the silk fibroin micro/nanofiber membrane in the obtained chitosan solution, make the membrane fully contact with the solution, take out the membrane after 20 minutes, wash it with deionized water three times to remove the unassembled chitosan on the membrane surface;

(3)蒙脱土加入到去离子水中,采用超声仪进行分散,制备得到浓度为1mg/mL的蒙脱土悬浮液,将组装了壳聚糖的丝素蛋白纳米纤维膜浸入到所得的蒙脱土悬浮液中,使膜与溶液充分接触,20分钟后将膜取出,采用去离子水清洗三次去除膜表面未组装成功的蒙脱土,至此组装成功了一个双层;(3) Montmorillonite is added to deionized water, dispersed by an ultrasonic instrument, and a suspension of montmorillonite with a concentration of 1mg/mL is prepared, and the silk fibroin nanofiber membrane assembled with chitosan is immersed in the obtained montmorillonite suspension. In the desoil suspension, make the membrane fully contact with the solution, take out the membrane after 20 minutes, wash it with deionized water three times to remove the unassembled montmorillonite on the surface of the membrane, and a double layer has been successfully assembled so far;

(4)依次重复步骤(2)和步骤(3)若干次,将所得微/纳米纤维膜干燥,即可获得双层数为所需层数的复合纳米纤维膜。(4) Step (2) and step (3) are repeated several times in sequence, and the obtained micro/nanofiber membrane is dried to obtain a composite nanofiber membrane with the required number of layers.

Claims (10)

1.一种用层状硅酸盐/壳聚糖层层自组装改性微/纳米纤维膜的方法,其特征在于:以带电荷的微/纳米纤维膜作为基板,当基板所带电荷为正时,依次在基板上组装层状硅酸盐和壳聚糖,直至达到所需双层数;当基板所带电荷为负时,依次在基板上组装壳聚糖和层状硅酸盐,直至达到所需双层数,将组装后的微/纳米纤维膜干燥,得到改性的微/纳米纤维膜。1. A method for modifying micro/nano fiber membranes with layered silicate/chitosan layer by layer self-assembly, is characterized in that: with charged micro/nano fiber membranes as substrate, when the charge of substrate is When the timing is positive, assemble layered silicate and chitosan on the substrate in sequence until the required number of double layers is reached; when the charge on the substrate is negative, assemble chitosan and layered silicate on the substrate in sequence, Until the desired number of double layers is reached, the assembled micro/nanofibrous membrane is dried to obtain a modified micro/nanofibrous membrane. 2.根据权利要求1所述的方法,其特征在于:所述基板的zeta电位绝对值不小于10mV。2. The method according to claim 1, characterized in that: the absolute value of the zeta potential of the substrate is not less than 10 mV. 3.根据权利要求1所述的方法,其特征在于:所述的所需双层数为1-50层。3. The method according to claim 1, characterized in that: the required number of double layers is 1-50 layers. 4.根据权利要求1所述的方法,其特征在于:所述的微/纳米纤维膜基板是由丝素蛋白、胶原蛋白、醋酸纤维素、壳聚糖及其衍生物、聚左旋乳酸、聚己内酯、聚乳酸-羟基乙酸共聚物中的一种或几种制备得到的。4. The method according to claim 1, characterized in that: the micro/nano fiber membrane substrate is made of silk fibroin, collagen, cellulose acetate, chitosan and derivatives thereof, poly-L-lactic acid, poly It is prepared by one or more of caprolactone and polylactic acid-glycolic acid copolymer. 5.根据权利要求1或4所述的方法,其特征在于:所述的微/纳米纤维膜基板由静电纺丝法、湿法纺丝法、干法纺丝法、离心纺丝法、相分离法或者复合纺丝法中的任一种制备得到。5. The method according to claim 1 or 4, characterized in that: the micro/nano fiber membrane substrate is formed by electrospinning, wet spinning, dry spinning, centrifugal spinning, phase spinning, etc. It can be prepared by any one of separation method or composite spinning method. 6.根据权利要求1所述的方法,其特征在于:所述的壳聚糖按照下述方法组装:配置壳聚糖醋酸溶液,将基板浸泡于带正电荷的壳聚糖醋酸溶液中,一定时间后,将膜取出,用清洗液清洗去除膜表面未组装成功的壳聚糖。6. method according to claim 1, is characterized in that: described chitosan is assembled according to following method: configuration chitosan acetic acid solution, substrate is soaked in the positively charged chitosan acetic acid solution, certain After a period of time, the membrane is taken out, and the unassembled chitosan on the surface of the membrane is removed by cleaning with a cleaning solution. 7.根据权利要求1所述的方法,其特征在于:所述的层状硅酸盐按照下述方法组装:配置层状硅酸盐悬浮液,将基板浸泡于带负电荷的层状硅酸盐悬浮液中,一定时间后,将膜取出,用清洗液清洗去除膜表面未组装成功的层状硅酸盐。7. The method according to claim 1, characterized in that: the phyllosilicate is assembled according to the following method: configure the phyllosilicate suspension, and soak the substrate in negatively charged phyllosilicate In the salt suspension, after a certain period of time, the membrane is taken out and washed with a cleaning solution to remove the unassembled phyllosilicate on the surface of the membrane. 8.根据权利要求1所述的方法,其特征在于:所述的层状硅酸盐为蒙脱土或累托石。8. The method according to claim 1, characterized in that: the layered silicate is montmorillonite or rectorite. 9.根据权利要求6或7所述的方法,其特征在于:所述的清洗液为去离子水或0.01-1mol/L的氯化钠溶液。9. The method according to claim 6 or 7, characterized in that: the cleaning solution is deionized water or 0.01-1mol/L sodium chloride solution. 10.一种用层状硅酸盐/壳聚糖层层自组装改性的微/纳米纤维膜,其特征在于:通过权利要求1-9任一项所述的方法制备得到。10. A micro/nano fiber membrane self-assembled and modified layer by layer silicate/chitosan, characterized in that it is prepared by the method according to any one of claims 1-9.
CN201710471996.8A 2017-06-20 2017-06-20 Method for modifying micro/nano fiber membrane by using layered silicate/chitosan layer-by-layer self-assembly Active CN107261209B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710471996.8A CN107261209B (en) 2017-06-20 2017-06-20 Method for modifying micro/nano fiber membrane by using layered silicate/chitosan layer-by-layer self-assembly

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710471996.8A CN107261209B (en) 2017-06-20 2017-06-20 Method for modifying micro/nano fiber membrane by using layered silicate/chitosan layer-by-layer self-assembly

Publications (2)

Publication Number Publication Date
CN107261209A true CN107261209A (en) 2017-10-20
CN107261209B CN107261209B (en) 2020-03-10

Family

ID=60067904

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201710471996.8A Active CN107261209B (en) 2017-06-20 2017-06-20 Method for modifying micro/nano fiber membrane by using layered silicate/chitosan layer-by-layer self-assembly

Country Status (1)

Country Link
CN (1) CN107261209B (en)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108187503A (en) * 2018-01-25 2018-06-22 安徽农业大学 A kind of preparation method of the enhanced chitosan multiple cellulose acetate film of montmorillonite
CN109777381A (en) * 2017-11-13 2019-05-21 中石化石油工程技术服务有限公司 A kind of method that montmorillonite self assembly is deposited on the surface of solids
CN109853219A (en) * 2019-01-14 2019-06-07 武汉佰玛生物科技有限公司 Modified composite fiber film and its LBL self-assembly methods and applications
CN110144124A (en) * 2019-05-07 2019-08-20 华中科技大学 A composite material of quaternized chitin and silk fibroin and its preparation and application
CN111420619A (en) * 2020-03-19 2020-07-17 南京航空航天大学 Preparation method of cellulose-chitosan/PANI composite aerogel
CN111545180A (en) * 2020-04-24 2020-08-18 陕西科技大学 Preparation method of cellulose acetate modified montmorillonite composite nanofiber
CN111617382A (en) * 2020-05-20 2020-09-04 四川大学华西医院 An electrical stimulation device for preventing pressure injury
CN115350318A (en) * 2022-07-22 2022-11-18 上海健康医学院 A chitosan/silk fibroin nanofiber drug-loaded multilayer film and its preparation method
CN115554992A (en) * 2021-06-30 2023-01-03 同济大学 Polymer-modified magnetic nano material, and preparation method and application thereof
CN117861452A (en) * 2024-03-11 2024-04-12 深圳格立菲环境科技有限公司 Hollow fiber ultrafiltration membrane and preparation method thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010123547A1 (en) * 2009-04-21 2010-10-28 Albert Einstein College Of Medicine Of Yeshiva University Versatile nanoparticulate biomaterial for controlled delivery and/or containment of therapeutic and diagnostic material
CN103536958A (en) * 2013-09-29 2014-01-29 武汉大学 Modified cellulose nanofiber membrane based on layer-by-layer self-assembly of lysozyme and silk protein based as well as preparation and application thereof
CN105714572A (en) * 2016-04-19 2016-06-29 武汉大学 Method for modifying high-molecular micro or nano fiber membrane through layer-by-layer assembling of coating machine

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010123547A1 (en) * 2009-04-21 2010-10-28 Albert Einstein College Of Medicine Of Yeshiva University Versatile nanoparticulate biomaterial for controlled delivery and/or containment of therapeutic and diagnostic material
CN103536958A (en) * 2013-09-29 2014-01-29 武汉大学 Modified cellulose nanofiber membrane based on layer-by-layer self-assembly of lysozyme and silk protein based as well as preparation and application thereof
CN105714572A (en) * 2016-04-19 2016-06-29 武汉大学 Method for modifying high-molecular micro or nano fiber membrane through layer-by-layer assembling of coating machine

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
YANG WU ET AL.: "Production of thick uniform-coating films containing rectorite on nanofibers through the use of an automated coating machine", 《COLLOIDS AND SURFACES B: BIOINTERFACES》 *
冯丽萍等: "《薄膜技术与应用》", 29 February 2016, 西北工业大学出版社 *
陈佳佳等: "壳聚糖/累托石层层自组装丝素纳米纤维膜的抑菌及生物相容性研究", 《中国第四届静电纺丝大会(CICE 2016)摘要集》 *

Cited By (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109777381A (en) * 2017-11-13 2019-05-21 中石化石油工程技术服务有限公司 A kind of method that montmorillonite self assembly is deposited on the surface of solids
CN108187503A (en) * 2018-01-25 2018-06-22 安徽农业大学 A kind of preparation method of the enhanced chitosan multiple cellulose acetate film of montmorillonite
CN109853219A (en) * 2019-01-14 2019-06-07 武汉佰玛生物科技有限公司 Modified composite fiber film and its LBL self-assembly methods and applications
CN109853219B (en) * 2019-01-14 2021-12-28 奥美佰玛(武汉)生物科技有限公司 Modified composite fiber membrane and layer-by-layer self-assembly method and application thereof
CN110144124B (en) * 2019-05-07 2020-07-10 华中科技大学 Composite material of quaternized chitin and silk fibroin and preparation and application thereof
CN110144124A (en) * 2019-05-07 2019-08-20 华中科技大学 A composite material of quaternized chitin and silk fibroin and its preparation and application
CN111420619A (en) * 2020-03-19 2020-07-17 南京航空航天大学 Preparation method of cellulose-chitosan/PANI composite aerogel
CN111420619B (en) * 2020-03-19 2022-04-05 南京航空航天大学 A kind of preparation method of cellulose-chitosan/PANI composite aerogel
CN111545180A (en) * 2020-04-24 2020-08-18 陕西科技大学 Preparation method of cellulose acetate modified montmorillonite composite nanofiber
CN111545180B (en) * 2020-04-24 2023-03-24 陕西科技大学 Preparation method of cellulose acetate modified montmorillonite composite nanofiber
CN111617382A (en) * 2020-05-20 2020-09-04 四川大学华西医院 An electrical stimulation device for preventing pressure injury
CN111617382B (en) * 2020-05-20 2023-08-25 四川大学华西医院 An electrical stimulation device for preventing pressure injury
CN115554992A (en) * 2021-06-30 2023-01-03 同济大学 Polymer-modified magnetic nano material, and preparation method and application thereof
CN115554992B (en) * 2021-06-30 2023-10-27 同济大学 Polymer modified magnetic nano material, preparation method and application thereof
CN115350318A (en) * 2022-07-22 2022-11-18 上海健康医学院 A chitosan/silk fibroin nanofiber drug-loaded multilayer film and its preparation method
CN117861452A (en) * 2024-03-11 2024-04-12 深圳格立菲环境科技有限公司 Hollow fiber ultrafiltration membrane and preparation method thereof
CN117861452B (en) * 2024-03-11 2024-05-28 深圳格立菲环境科技有限公司 Hollow fiber ultrafiltration membrane and preparation method thereof

Also Published As

Publication number Publication date
CN107261209B (en) 2020-03-10

Similar Documents

Publication Publication Date Title
CN107261209B (en) Method for modifying micro/nano fiber membrane by using layered silicate/chitosan layer-by-layer self-assembly
CN101798756B (en) Biomedical material preparation method of electrostatic self-assembly modified nanofiber
Bhattarai et al. Alginate‐based nanofibrous scaffolds: Structural, mechanical, and biological properties
CN104436285B (en) A kind of regenerated silk fibroin gel film and its preparation method
Han et al. A review: current status and emerging developments on natural polymer‐based electrospun fibers
Chen et al. A comprehensive review of electrospinning block copolymers
Singh et al. A novel electrospinning approach to fabricate high strength aqueous silk fibroin nanofibers
CN110872741B (en) Composite nanofiber membrane simultaneously used for emulsion separation and dye adsorption and preparation method thereof
CN103341209A (en) Silk fibroin nanofiber membrane and preparation method thereof
Yadav et al. Electrospinning: an efficient biopolymer-based micro-and nanofibers fabrication technique
CN106798948A (en) A kind of method of regulation and control biofilm surface topological structure to promote cell to creep
CN103981561B (en) Preparation method, device and the application thereof of a kind of voltolisation fibroin aquagel membrane
CN102357264B (en) Silk fibroin porous material and preparation method thereof and tissue engineering stent
CN107149699A (en) A kind of neural tissue engineering conductive fiber tubular bracket and preparation method thereof
CN109853219B (en) Modified composite fiber membrane and layer-by-layer self-assembly method and application thereof
CN109806771B (en) Nanofiber-based composite hemodialysis membrane and preparation method thereof
CN104153120A (en) Antibacterial medical dressing film carrying nano-silver and cellulose nanocrystalline hybrid materials and preparation method thereof
CN101270199A (en) Method for Improving Hydrophilicity of Polyacrylonitrile Hydroxyethyl Cellulose Nanocomposite Fiber Membrane
CN103789874A (en) Method for preparing polyelectrolyte nano fibers in core-shell structures by parallel electric field inductive phase separation method
CN110029499A (en) Medical high polymer three-dimensional structure composite material and preparation method
CN102277654B (en) Preparation method of hyaluronic acid and chitosan composite polyelectrolyte nanofibers
KR101828925B1 (en) Low density nanofiber, a process for the preparation thereof, and a use thereof
CN111996677A (en) Antibacterial MoS2Preparation method of PLGA nanofiber membrane
CN110592947A (en) Preparation method of polyhydroxyalkanoate/polydopamine composite electrospun membrane and electrospun membrane
CN102926027B (en) Method for preparing modified konjac glucomannan/biodegradation polyester polyblend fibers through electrostatic spinning

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant